DNA/NN
methylation/NN
changes/NNS
in/IN
hematologic/JJ
malignancies/NNS
:/:
biologic/JJ
and/CC
clinical/JJ
implications/NNS
./.

DNA/NN
methylation/NN
changes/NNS
are/VBP
among/IN
the/DT
most/RBS
common/JJ
detectable/JJ
abnormalities/NNS
in/IN
human/JJ
neoplasia/NN
./.
=====
Hypermethylation/NN
within/IN
the/DT
promoters/NNS
of/IN
selected/VBN
genes/NNS
appears/VBZ
to/TO
be/VB
especially/RB
common/JJ
in/IN
all/DT
types/NNS
of/IN
human/JJ
hematopoietic/JJ
neoplasms/NNS
,/,
and/CC
is/VBZ
usually/RB
associated/VBN
with/IN
inactivation/NN
of/IN
the/DT
involved/VBN
gene/NN
(/(
s/NNS
)/)
./.
=====
Such/JJ
hypermethylation-associated/JJ
silencing/NN
of/IN
gene/NN
expression/NN
has/VBZ
been/VBN
shown/VBN
for/IN
several/JJ
genes/NNS
regulating/VBG
the/DT
growth/NN
and/CC
differentiation/NN
of/IN
hematopoietic/JJ
cells/NNS
,/,
including/VBG
the/DT
estrogen/NN
receptor/NN
(/(
ER/NN
)/)
gene/NN
,/,
P15/NN
,/,
P16/NN
and/CC
others/NNS
./.
=====
Hypermethylation/NN
within/IN
the/DT
promoters/NNS
of/IN
some/DT
genes/NNS
appear/VBP
to/TO
be/VB
an/DT
early/JJ
event/NN
in/IN
the/DT
pathogenesis/NN
of/IN
neoplasia/NN
(/(
ER/NN
,/,
P15/NN
)/)
,/,
while/IN
other/JJ
genes/NNS
seem/VBP
to/TO
become/VB
methylated/VBN
during/IN
the/DT
progression/NN
of/IN
leukemias/NNS
(/(
HIC1/NN
,/,
c-abl/NN
)/)
./.
=====
The/DT
high/JJ
prevalence/NN
of/IN
promoter/NN
methylation/NN
suggests/VBZ
that/IN
this/DT
molecular/JJ
abnormality/NN
can/MD
be/VB
used/VBN
to/TO
monitor/VB
disease/NN
activity/NN
during/IN
therapy/NN
./.
=====
In/IN
addition/NN
,/,
new/JJ
technology/NN
allows/VBZ
the/DT
sensitive/JJ
identification/NN
of/IN
gene/NN
hypermethylation/NN
in/IN
a/DT
background/NN
of/IN
normal/JJ
cells/NNS
,/,
suggesting/VBG
possible/JJ
new/JJ
strategies/NNS
for/IN
the/DT
detection/NN
of/IN
minimal/JJ
residual/JJ
disease/NN
./.
=====
Finally/RB
,/,
reactivation/NN
of/IN
tumor-suppressor/JJ
gene/NN
expression/NN
through/IN
pharmacologic/JJ
inhibition/NN
of/IN
DNA/NN
methyltransferase/NN
and/CC
resultant/JJ
DNA/NN
demethylation/NN
appears/VBZ
to/TO
be/VB
a/DT
promising/JJ
new/JJ
avenue/NN
of/IN
therapy/NN
in/IN
acute/JJ
leukemia/NN
./.